#begin document (nw/wsj/19/wsj_1934); part 000
nw/wsj/19/wsj_1934   0    0               A    DT  (TOP(S(NP(NP*         -    -   -   -            *   (ARG3*        (ARG1*   -
nw/wsj/19/wsj_1934   0    1             new    JJ              *         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0    2            drug    NN              *)        -    -   -   -            *        *)            *   -
nw/wsj/19/wsj_1934   0    3              to    TO    (SBAR(S(VP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0    4         prevent    VB           (VP*    prevent  01   1   -            *      (V*)            *   -
nw/wsj/19/wsj_1934   0    5             the    DT        (NP(NP*         -    -   -   -            *   (ARG1*             *   -
nw/wsj/19/wsj_1934   0    6       rejection    NN              *)        -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0    7              of    IN           (PP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0    8    transplanted    JJ           (NP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0    9          organs   NNS       *))))))))        -    -   -   -            *        *)            *)  -
nw/wsj/19/wsj_1934   0   10             has   VBZ           (VP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   11            been   VBN           (VP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   12    successfully    RB         (ADVP*)        -    -   -   -            *        *    (ARGM-MNR*)  -
nw/wsj/19/wsj_1934   0   13            used   VBN           (VP*        use  01   -   -            *        *           (V*)  -
nw/wsj/19/wsj_1934   0   14              on    IN           (PP*         -    -   -   -            *        *    (ARGM-LOC*   -
nw/wsj/19/wsj_1934   0   15            more   JJR        (NP(QP*         -    -   -   -   (CARDINAL*        *             *   -
nw/wsj/19/wsj_1934   0   16            than    IN              *         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   17            100     CD              *)        -    -   -   -            *)       *             *   -
nw/wsj/19/wsj_1934   0   18        patients   NNS             *))        -    -   -   -            *        *             *)  -
nw/wsj/19/wsj_1934   0   19              at    IN           (PP*         -    -   -   -            *        *    (ARGM-TMP*   -
nw/wsj/19/wsj_1934   0   20             the    DT        (NP(NP*         -    -   -   -        (ORG*        *             *   -
nw/wsj/19/wsj_1934   0   21      University   NNP              *)        -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   22              of    IN           (PP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   23      Pittsburgh   NNP        (NP*))))        -    -   -   -            *)       *             *)  -
nw/wsj/19/wsj_1934   0   24               ,     ,              *         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   25       according   VBG           (PP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   26              to    IN           (PP*         -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   27     researchers   NNS      (NP*))))))        -    -   -   -            *        *             *   -
nw/wsj/19/wsj_1934   0   28               .     .             *))        -    -   -   -            *        *             *   -

nw/wsj/19/wsj_1934   0    0             The     DT  (TOP(S(S(NP(NP*         -    -   -   -       *        (ARG1*        (ARG1*         *   -
nw/wsj/19/wsj_1934   0    1            drug     NN                *)        -    -   -   -       *             *)            *         *   -
nw/wsj/19/wsj_1934   0    2               ,      ,                *         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0    3           which    WDT      (SBAR(WHNP*)        -    -   -   -       *      (R-ARG1*)            *         *   -
nw/wsj/19/wsj_1934   0    4              is    VBZ           (S(VP*         be  01   -   -       *           (V*)            *         *   -
nw/wsj/19/wsj_1934   0    5           still     RB           (ADVP*)        -    -   -   -       *    (ARGM-TMP*)            *         *   -
nw/wsj/19/wsj_1934   0    6              in     IN             (PP*         -    -   -   -       *        (ARG2*             *         *   -
nw/wsj/19/wsj_1934   0    7             the     DT             (NP*         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0    8    experimental     JJ                *         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0    9           phase     NN            *)))))        -    -   -   -       *             *)            *         *   -
nw/wsj/19/wsj_1934   0   10               ,      ,                *)        -    -   -   -       *             *             *)        *   -
nw/wsj/19/wsj_1934   0   11             has    VBZ             (VP*         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   12             n't     RB                *         -    -   -   -       *             *    (ARGM-NEG*)        *   -
nw/wsj/19/wsj_1934   0   13            been    VBN             (VP*         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   14        approved    VBN             (VP*    approve  01   -   -       *             *           (V*)        *   -
nw/wsj/19/wsj_1934   0   15             yet     RB           (ADVP*)        -    -   -   -       *             *    (ARGM-TMP*)        *   -
nw/wsj/19/wsj_1934   0   16              by     IN             (PP*         -    -   -   -       *             *        (ARG0*         *   -
nw/wsj/19/wsj_1934   0   17             the     DT             (NP*         -    -   -   -   (ORG*             *             *         *   -
nw/wsj/19/wsj_1934   0   18            Food    NNP            (NML*         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   19             and     CC                *         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   20            Drug    NNP                *)        -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   21    Admistration    NNP           *))))))        -    -   -   -       *)            *             *)        *   -
nw/wsj/19/wsj_1934   0   22               ,      ,                *         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   23             and     CC                *         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   24             its   PRP$           (S(NP*         -    -   -   -       *             *             *    (ARG1*   -
nw/wsj/19/wsj_1934   0   25            long     JJ            (NML*         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   26              -    HYPH                *         -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   27            term     NN                *)        -    -   -   -       *             *             *         *   -
nw/wsj/19/wsj_1934   0   28         effects    NNS                *)        -    -   -   -       *             *             *         *)  -
nw/wsj/19/wsj_1934   0   29             are    VBP             (VP*         be  01   -   -       *             *             *       (V*)  -
nw/wsj/19/wsj_1934   0   30         unknown     JJ         (ADJP*)))        -    -   -   -       *             *             *    (ARG2*)  -
nw/wsj/19/wsj_1934   0   31               .      .               *))        -    -   -   -       *             *             *         *   -

nw/wsj/19/wsj_1934   0    0                But     CC         (TOP(S*               -    -   -   -   *    (ARGM-DIS*)       *             *        *        *   -
nw/wsj/19/wsj_1934   0    1        researchers    NNS            (NP*)              -    -   -   -   *        (ARG0*)       *             *        *        *   -
nw/wsj/19/wsj_1934   0    2                say    VBP            (VP*              say  01   -   -   *           (V*)       *             *        *        *   -
nw/wsj/19/wsj_1934   0    3                the     DT  (SBAR(S(NP(NP*               -    -   -   -   *        (ARG1*   (ARG1*        (ARG0*   (ARG0*   (ARG0*   -
nw/wsj/19/wsj_1934   0    4               drug     NN               *)              -    -   -   -   *             *        *)            *        *        *   -
nw/wsj/19/wsj_1934   0    5                  ,      ,               *               -    -   -   -   *             *        *             *        *        *   -
nw/wsj/19/wsj_1934   0    6             called    VBN            (VP*             call  01   -   -   *             *      (V*)            *        *        *   -
nw/wsj/19/wsj_1934   0    7                 FK    NNP          (S(NP*               -    -   -   -   *             *   (ARG2*             *        *        *   -
nw/wsj/19/wsj_1934   0    8                 -    HYPH               *               -    -   -   -   *             *        *             *        *        *   -
nw/wsj/19/wsj_1934   0    9               506      CD             *)))              -    -   -   -   *             *        *)            *        *        *   -
nw/wsj/19/wsj_1934   0   10                  ,      ,               *)              -    -   -   -   *             *        *             *)       *)       *)  -
nw/wsj/19/wsj_1934   0   11              could     MD            (VP*               -    -   -   -   *             *        *    (ARGM-MOD*)       *        *   -
nw/wsj/19/wsj_1934   0   12      revolutionize     VB            (VP*    revolutionize  01   -   -   *             *        *           (V*)       *        *   -
nw/wsj/19/wsj_1934   0   13                the     DT            (NP*               -    -   -   -   *             *        *        (ARG1*        *        *   -
nw/wsj/19/wsj_1934   0   14    transplantation     NN               *               -    -   -   -   *             *        *             *        *        *   -
nw/wsj/19/wsj_1934   0   15              field     NN               *)              -    -   -   -   *             *        *             *)       *        *   -
nw/wsj/19/wsj_1934   0   16                 by     IN         (PP(PP*               -    -   -   -   *             *        *    (ARGM-MNR*        *        *   -
nw/wsj/19/wsj_1934   0   17           reducing    VBG          (S(VP*           reduce  01   -   -   *             *        *             *      (V*)       *   -
nw/wsj/19/wsj_1934   0   18            harmful     JJ            (NP*               -    -   -   -   *             *        *             *   (ARG1*        *   -
nw/wsj/19/wsj_1934   0   19               side     JJ               *               -    -   -   -   *             *        *             *        *        *   -
nw/wsj/19/wsj_1934   0   20            effects    NNS            *))))              -    -   -   -   *             *        *             *        *)       *   -
nw/wsj/19/wsj_1934   0   21                and     CC               *               -    -   -   -   *             *        *             *        *        *   -
nw/wsj/19/wsj_1934   0   22                 by     IN            (PP*               -    -   -   -   *             *        *             *        *        *   -
nw/wsj/19/wsj_1934   0   23           lowering    VBG          (S(VP*            lower  01   2   -   *             *        *             *        *      (V*)  -
nw/wsj/19/wsj_1934   0   24          rejection     NN            (NP*               -    -   -   -   *             *        *             *        *   (ARG1*   -
nw/wsj/19/wsj_1934   0   25              rates    NNS      *))))))))))              -    -   -   -   *             *)       *             *)       *        *)  -
nw/wsj/19/wsj_1934   0   26                  .      .              *))              -    -   -   -   *             *        *             *        *        *   -

nw/wsj/19/wsj_1934   0    0        Rejection     NN   (TOP(S(NP*)        -    -   -   -            *       (ARG1*)           *   -
nw/wsj/19/wsj_1934   0    1              has    VBZ         (VP*         -    -   -   -            *            *            *   -
nw/wsj/19/wsj_1934   0    2             been    VBN         (VP*         be  01   -   -            *          (V*)           *   -
nw/wsj/19/wsj_1934   0    3              the     DT         (NP*         -    -   -   -            *       (ARG2*            *   -
nw/wsj/19/wsj_1934   0    4            major     JJ            *         -    -   -   -            *            *            *   -
nw/wsj/19/wsj_1934   0    5         obstacle     NN            *)        -    -   -   -            *            *)           *   -
nw/wsj/19/wsj_1934   0    6               in     IN         (PP*         -    -   -   -            *   (ARGM-LOC*            *   -
nw/wsj/19/wsj_1934   0    7              the     DT      (NP(NP*         -    -   -   -            *            *       (ARG1*   -
nw/wsj/19/wsj_1934   0    8    approximately     RB         (QP*         -    -   -   -   (CARDINAL*            *            *   -
nw/wsj/19/wsj_1934   0    9          30,000      CD            *)        -    -   -   -            *)           *            *   -
nw/wsj/19/wsj_1934   0   10            organ     NN            *         -    -   -   -            *            *            *   -
nw/wsj/19/wsj_1934   0   11      transplants    NNS            *)        -    -   -   -            *            *            *)  -
nw/wsj/19/wsj_1934   0   12        performed    VBN         (VP*    perform  01   -   -            *            *          (V*)  -
nw/wsj/19/wsj_1934   0   13            world     NN       (ADVP*         -    -   -   -            *            *   (ARGM-LOC*   -
nw/wsj/19/wsj_1934   0   14               -    HYPH            *         -    -   -   -            *            *            *   -
nw/wsj/19/wsj_1934   0   15             wide     RB            *)        -    -   -   -            *            *            *)  -
nw/wsj/19/wsj_1934   0   16             each     DT         (NP*         -    -   -   -       (DATE*            *   (ARGM-TMP*   -
nw/wsj/19/wsj_1934   0   17             year     NN       *))))))        -    -   -   -            *)           *)           *)  -
nw/wsj/19/wsj_1934   0   18                .      .           *))        -    -   -   -            *            *            *   -

nw/wsj/19/wsj_1934   0    0    Researchers   NNS    (TOP(S(NP*)        -    -   -   -        *       (ARG0*)   (ARG0*)          *   -
nw/wsj/19/wsj_1934   0    1          began   VBD          (VP*      begin  01   -   -        *          (V*)        *           *   -
nw/wsj/19/wsj_1934   0    2          using   VBG        (S(VP*        use  01   -   -        *       (ARG1*       (V*)          *   -
nw/wsj/19/wsj_1934   0    3            the    DT          (NP*         -    -   -   -        *            *    (ARG1*           *   -
nw/wsj/19/wsj_1934   0    4           drug    NN           *)))        -    -   -   -        *            *)        *)          *   -
nw/wsj/19/wsj_1934   0    5             in    IN          (PP*         -    -   -   -        *   (ARGM-TMP*         *           *   -
nw/wsj/19/wsj_1934   0    6       February   NNP         (NP*))        -    -   -   -    (DATE)           *)        *           *   -
nw/wsj/19/wsj_1934   0    7             on    IN          (PP*         -    -   -   -        *   (ARGM-ADV*         *           *   -
nw/wsj/19/wsj_1934   0    8       patients   NNS       (NP(NP*)        -    -   -   -        *            *         *      (ARG0*)  -
nw/wsj/19/wsj_1934   0    9            who    WP   (SBAR(WHNP*)        -    -   -   -        *            *         *    (R-ARG0*)  -
nw/wsj/19/wsj_1934   0   10            had   VBD        (S(VP*         -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   11       received   VBN          (VP*    receive  01   -   -        *            *         *         (V*)  -
nw/wsj/19/wsj_1934   0   12         kidney    NN      (NP(NML*         -    -   -   -        *            *         *      (ARG1*   -
nw/wsj/19/wsj_1934   0   13              ,     ,             *         -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   14          liver    NN             *         -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   15              ,     ,             *         -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   16          heart    NN             *         -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   17            and    CC             *         -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   18       pancreas    NN             *)        -    -   -   -        *            *         *           *   -
nw/wsj/19/wsj_1934   0   19    transplants   NNS      *))))))))        -    -   -   -        *            *)        *           *)  -
nw/wsj/19/wsj_1934   0   20              .     .            *))        -    -   -   -        *            *         *           *   -

nw/wsj/19/wsj_1934   0   0           Only    RB  (TOP(S(NP(QP*        -    -   -   -   (CARDINAL*   (ARG1*   -
nw/wsj/19/wsj_1934   0   1            two    CD              *        -    -   -   -            *)       *   -
nw/wsj/19/wsj_1934   0   2             of    IN              *        -    -   -   -            *        *   -
nw/wsj/19/wsj_1934   0   3           111     CD              *)       -    -   -   -    (CARDINAL)       *   -
nw/wsj/19/wsj_1934   0   4    transplants   NNS              *)       -    -   -   -            *        *)  -
nw/wsj/19/wsj_1934   0   5           have   VBP           (VP*        -    -   -   -            *        *   -
nw/wsj/19/wsj_1934   0   6           been   VBN           (VP*        -    -   -   -            *        *   -
nw/wsj/19/wsj_1934   0   7       rejected   VBN         (VP*)))   reject  01   -   -            *      (V*)  -
nw/wsj/19/wsj_1934   0   8              .     .             *))       -    -   -   -            *        *   -

nw/wsj/19/wsj_1934   0    0            The    DT  (TOP(S(NP(NP*            -    -   -   -        *       (ARG1*   (ARG1*            *   -
nw/wsj/19/wsj_1934   0    1           drug    NN              *)           -    -   -   -        *            *)       *            *   -
nw/wsj/19/wsj_1934   0    2              ,     ,              *            -    -   -   -        *            *        *            *   -
nw/wsj/19/wsj_1934   0    3     discovered   VBN           (VP*      discover  01   -   -        *          (V*)       *            *   -
nw/wsj/19/wsj_1934   0    4             in    IN           (PP*            -    -   -   -        *   (ARGM-TMP*        *            *   -
nw/wsj/19/wsj_1934   0    5          1984     CD         (NP*)))           -    -   -   -    (DATE)           *)       *            *   -
nw/wsj/19/wsj_1934   0    6              ,     ,              *)           -    -   -   -        *            *        *)           *   -
nw/wsj/19/wsj_1934   0    7             is   VBZ           (VP*            -    -   -   -        *            *        *            *   -
nw/wsj/19/wsj_1934   0    8    metabolized   VBN           (VP*    metabolize  01   -   -        *            *      (V*)           *   -
nw/wsj/19/wsj_1934   0    9           from    IN           (PP*            -    -   -   -        *            *   (ARG2*            *   -
nw/wsj/19/wsj_1934   0   10           soil    NN        (NP(NP*            -    -   -   -        *            *        *       (ARG1*   -
nw/wsj/19/wsj_1934   0   11         fungus    NN              *)           -    -   -   -        *            *        *            *)  -
nw/wsj/19/wsj_1934   0   12          found   VBN           (VP*          find  01   -   -        *            *        *          (V*)  -
nw/wsj/19/wsj_1934   0   13             in    IN           (PP*            -    -   -   -        *            *        *   (ARGM-LOC*   -
nw/wsj/19/wsj_1934   0   14          Japan   NNP     (NP*)))))))           -    -   -   -     (GPE)           *        *)           *)  -
nw/wsj/19/wsj_1934   0   15              .     .             *))           -    -   -   -        *            *        *            *   -

nw/wsj/19/wsj_1934   0    0               The    DT       (TOP(S(NP*      -    -   -   -       *   (ARG1*        *           *   -
nw/wsj/19/wsj_1934   0    1        Pittsburgh   NNP                *      -    -   -   -    (GPE)       *        *           *   -
nw/wsj/19/wsj_1934   0    2          patients   NNS                *)     -    -   -   -       *        *)       *           *   -
nw/wsj/19/wsj_1934   0    3               are   VBP             (VP*      be  01   -   -       *      (V*)       *           *   -
nw/wsj/19/wsj_1934   0    4               the    DT          (NP(NP*      -    -   -   -       *   (ARG2*   (ARG2*           *   -
nw/wsj/19/wsj_1934   0    5             first    JJ                *      -    -   -   -       *        *        *           *   -
nw/wsj/19/wsj_1934   0    6            humans   NNS                *)     -    -   -   -       *        *        *)          *   -
nw/wsj/19/wsj_1934   0    7                to    TO      (SBAR(S(VP*      -    -   -   -       *        *        *           *   -
nw/wsj/19/wsj_1934   0    8                be    VB             (VP*      -    -   -   -       *        *        *           *   -
nw/wsj/19/wsj_1934   0    9             given   VBN             (VP*    give  01   -   -       *        *      (V*)          *   -
nw/wsj/19/wsj_1934   0   10               the    DT          (NP(NP*      -    -   -   -       *        *   (ARG1*      (ARG1*   -
nw/wsj/19/wsj_1934   0   11              drug    NN                *)     -    -   -   -       *        *        *           *)  -
nw/wsj/19/wsj_1934   0   12                 ,     ,                *      -    -   -   -       *        *        *           *   -
nw/wsj/19/wsj_1934   0   13             which   WDT      (SBAR(WHNP*)     -    -   -   -       *        *        *    (R-ARG1*)  -
nw/wsj/19/wsj_1934   0   14                is   VBZ           (S(VP*      -    -   -   -       *        *        *           *   -
nw/wsj/19/wsj_1934   0   15              made   VBN             (VP*    make  01   -   -       *        *        *         (V*)  -
nw/wsj/19/wsj_1934   0   16                by    IN             (PP*      -    -   -   -       *        *        *      (ARG0*   -
nw/wsj/19/wsj_1934   0   17          Fujisawa   NNP             (NP*      -    -   -   -   (ORG*        *        *           *   -
nw/wsj/19/wsj_1934   0   18    Pharmaceutical   NNP                *      -    -   -   -       *        *        *           *   -
nw/wsj/19/wsj_1934   0   19                Co   NNP   *))))))))))))))     -    -   -   -       *)       *)       *)          *)  -
nw/wsj/19/wsj_1934   0   20                 .     .               *))     -    -   -   -       *        *        *           *   -

nw/wsj/19/wsj_1934   0    0                 ``    ``  (TOP(SINV*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0    1                 We   PRP      (S(NP*)     -    -   -   -          *      *      *            *        (ARG1*   -
nw/wsj/19/wsj_1934   0    2                're   VBP        (VP*      be  03   -   -          *    (V*)     *            *             *   -
nw/wsj/19/wsj_1934   0    3            shocked    JJ        (VP*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0    4                 by    IN        (PP*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0    5                 it   PRP     (NP*))))     -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0    6                  ,     ,           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0    7            because    IN      (SBAR*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0    8                 it   PRP      (S(NP*)     -    -   -   -          *      *      *       (ARG0*)            *   -
nw/wsj/19/wsj_1934   0    9                 's   VBZ        (VP*    have  01   -   -          *      *    (V*)           *             *   -
nw/wsj/19/wsj_1934   0   10             worked   VBN        (VP*    work  01   -   -          *      *      *          (V*)            *   -
nw/wsj/19/wsj_1934   0   11                 so    RB      (ADVP*      -    -   -   -          *      *      *   (ARGM-MNR*             *   -
nw/wsj/19/wsj_1934   0   12               fast    RB      *))))))     -    -   -   -          *      *      *            *)            *)  -
nw/wsj/19/wsj_1934   0   13                  ,     ,           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   14                 ''    ''           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   15               said   VBD        (VP*)    say  01   -   -          *      *      *            *           (V*)  -
nw/wsj/19/wsj_1934   0   16                Dr.   NNP     (NP(NP*      -    -   -   -          *      *      *            *        (ARG0*   -
nw/wsj/19/wsj_1934   0   17             Thomas   NNP           *      -    -   -   -   (PERSON*      *      *            *             *   -
nw/wsj/19/wsj_1934   0   18                 E.   NNP           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   19             Starzl   NNP           *)     -    -   -   -          *)     *      *            *             *   -
nw/wsj/19/wsj_1934   0   20                  ,     ,           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   21           director    NN     (NP(NP*)     -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   22                 of    IN        (PP*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   23                the    DT        (NP*      -    -   -   -      (ORG*      *      *            *             *   -
nw/wsj/19/wsj_1934   0   24         University   NNP   (NML(NML*)     -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   25                 of    IN        (PP*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   26         Pittsburgh   NNP      (NP*)))     -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   27    Transplantation   NNP           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   28            Program   NNP         *)))     -    -   -   -          *)     *      *            *             *   -
nw/wsj/19/wsj_1934   0   29                  ,     ,           *)     -    -   -   -          *      *      *            *             *)  -
nw/wsj/19/wsj_1934   0   30                 at    IN        (PP*      -    -   -   -          *      *      *            *    (ARGM-LOC*   -
nw/wsj/19/wsj_1934   0   31                  a    DT        (NP*      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   32               news    NN           *      -    -   -   -          *      *      *            *             *   -
nw/wsj/19/wsj_1934   0   33         conference    NN          *))     -    -   -   -          *      *      *            *             *)  -
nw/wsj/19/wsj_1934   0   34               here    RB      (ADVP*)     -    -   -   -          *      *      *            *    (ARGM-LOC*)  -
nw/wsj/19/wsj_1934   0   35          yesterday    NN        (NP*)     -    -   -   -      (DATE)     *      *            *    (ARGM-TMP*)  -
nw/wsj/19/wsj_1934   0   36                  .     .          *))     -    -   -   -          *      *      *            *             *   -

nw/wsj/19/wsj_1934   0    0              ``     ``    (TOP(SINV*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0    1              We    PRP        (S(NP*)         -    -   -   -          *    (ARG0*)  (ARG1*   -
nw/wsj/19/wsj_1934   0    2        consider    VBP          (VP*    consider  01   -   -          *       (V*)       *   -
nw/wsj/19/wsj_1934   0    3              it    PRP        (S(NP*)         -    -   -   -          *    (ARG1*        *   -
nw/wsj/19/wsj_1934   0    4               a     DT       (NP(NP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0    5            life     NN        (ADJP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0    6              -    HYPH             *          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0    7          saving    VBG             *)         -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0    8            drug     NN             *)         -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0    9               ,      ,             *          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   10            like     IN          (PP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   11             one     CD       (NP(NP*)         -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   12             for     IN          (PP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   13            AIDS    NNP   (NP*))))))))         -    -   -   -          *         *)       *)  -
nw/wsj/19/wsj_1934   0   14               ,      ,             *          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   15              ''     ''             *          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   16            said    VBD          (VP*)        say  01   -   -          *         *      (V*)  -
nw/wsj/19/wsj_1934   0   17             Dr.    NNP       (NP(NP*          -    -   -   -          *         *   (ARG0*   -
nw/wsj/19/wsj_1934   0   18            John    NNP             *          -    -   -   -   (PERSON*         *        *   -
nw/wsj/19/wsj_1934   0   19            Fung    NNP             *)         -    -   -   -          *)        *        *   -
nw/wsj/19/wsj_1934   0   20               ,      ,             *          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   21              an     DT       (NP(NP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   22    immunologist     NN             *)         -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   23              at     IN          (PP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   24             the     DT       (NP(NP*          -    -   -   -      (ORG*         *        *   -
nw/wsj/19/wsj_1934   0   25      University    NNP             *)         -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   26              of     IN          (PP*          -    -   -   -          *         *        *   -
nw/wsj/19/wsj_1934   0   27      Pittsburgh    NNP     (NP*))))))         -    -   -   -          *)        *        *)  -
nw/wsj/19/wsj_1934   0   28               .      .            *))         -    -   -   -          *         *        *   -

nw/wsj/19/wsj_1934   0    0       Researchers    NNS      (TOP(S(NP*)        -    -   -   -            *    (ARG0*)        *        *           *   -
nw/wsj/19/wsj_1934   0    1               say    VBP            (VP*        say  01   -   -            *       (V*)        *        *           *   -
nw/wsj/19/wsj_1934   0    2              they    PRP     (SBAR(S(NP*)        -    -   -   -            *    (ARG1*    (ARG0*)       *           *   -
nw/wsj/19/wsj_1934   0    3           believe    VBP            (VP*    believe  01   -   -            *         *       (V*)       *           *   -
nw/wsj/19/wsj_1934   0    4                FK    NNP     (SBAR(S(NP*         -    -   -   -            *         *    (ARG1*   (ARG1*           *   -
nw/wsj/19/wsj_1934   0    5                -    HYPH               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0    6              506      CD               *)        -    -   -   -            *         *         *        *)          *   -
nw/wsj/19/wsj_1934   0    7                is    VBZ            (VP*         be  01   -   -            *         *         *      (V*)          *   -
nw/wsj/19/wsj_1934   0    8              100      CD  (ADJP(ADJP(QP*         -    -   -   -    (CARDINAL)        *         *   (ARG2*           *   -
nw/wsj/19/wsj_1934   0    9             times    NNS               *)        -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   10              more    RBR               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   11         effective     JJ               *)        -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   12              than     IN            (PP*         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   13               the     DT      (NP(NP(NP*         -    -   -   -            *         *         *        *      (ARG1*   -
nw/wsj/19/wsj_1934   0   14       traditional     JJ               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   15    anti-rejection     JJ               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   16              drug     NN               *)        -    -   -   -            *         *         *        *           *)  -
nw/wsj/19/wsj_1934   0   17                 ,      ,               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   18      cyclosporine     NN           (NP*))        -    -   -   -            *         *         *        *    (C-ARG1*)  -
nw/wsj/19/wsj_1934   0   19                 ,      ,               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   20              made    VBN            (VP*       make  01   -   -            *         *         *        *         (V*)  -
nw/wsj/19/wsj_1934   0   21                by     IN            (PP*         -    -   -   -            *         *         *        *      (ARG0*   -
nw/wsj/19/wsj_1934   0   22             Swiss     JJ        (NP(NML*         -    -   -   -        (NORP)        *         *        *           *   -
nw/wsj/19/wsj_1934   0   23    pharmaceutical     NN               *         -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   24             giant     NN               *)        -    -   -   -            *         *         *        *           *   -
nw/wsj/19/wsj_1934   0   25            Sandoz    NNP               *         -    -   -   -        (ORG*         *         *        *           *   -
nw/wsj/19/wsj_1934   0   26               Ltd    NNP   *)))))))))))))        -    -   -   -            *)        *)        *)       *)          *)  -
nw/wsj/19/wsj_1934   0   27                 .      .              *))        -    -   -   -            *         *         *        *           *   -

nw/wsj/19/wsj_1934   0    0            They    PRP      (TOP(S(NP*)          -    -   -   -   *        (ARG1*)            *   -
nw/wsj/19/wsj_1934   0    1             are    VBP            (VP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0    2            also     RB          (ADVP*)          -    -   -   -   *    (ARGM-ADV*)            *   -
nw/wsj/19/wsj_1934   0    3      encouraged    VBN            (VP*    encourage  02   -   -   *           (V*)            *   -
nw/wsj/19/wsj_1934   0    4              by     IN            (PP*           -    -   -   -   *        (ARG0*             *   -
nw/wsj/19/wsj_1934   0    5             the     DT         (NP(NP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0    6      relatively     RB          (ADJP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0    7            mild     JJ               *)          -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0    8            side     JJ               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0    9         effects    NNS               *)          -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   10              of     IN            (PP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   11              FK    NNP            (NP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   12              -    HYPH               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   13            506      CD              *))          -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   14               ,      ,               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   15        compared    VBN            (PP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   16            with     IN            (PP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   17    cyclosporine     NN         (NP(NP*)          -    -   -   -   *             *        (ARG0*)  -
nw/wsj/19/wsj_1934   0   18               ,      ,               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   19           which    WDT     (SBAR(WHNP*)          -    -   -   -   *             *      (R-ARG0*)  -
nw/wsj/19/wsj_1934   0   20             can     MD          (S(VP*           -    -   -   -   *             *    (ARGM-MOD*)  -
nw/wsj/19/wsj_1934   0   21           cause     VB            (VP*        cause  01   1   -   *             *           (V*)  -
nw/wsj/19/wsj_1934   0   22           renal     JJ         (NP(NP*           -    -   -   -   *             *        (ARG1*   -
nw/wsj/19/wsj_1934   0   23         failure     NN               *)          -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   24               ,      ,               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   25       morbidity     NN            (NP*)          -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   26               ,      ,               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   27          nausea     NN            (NP*)          -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   28             and     CC               *           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   29           other     JJ            (NP*           -    -   -   -   *             *             *   -
nw/wsj/19/wsj_1934   0   30        problems    NNS   *)))))))))))))          -    -   -   -   *             *)            *)  -
nw/wsj/19/wsj_1934   0   31               .      .              *))          -    -   -   -   *             *             *   -

nw/wsj/19/wsj_1934   0    0              ``      ``    (TOP(S*      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    1             The      DT  (S(NP(NP*      -    -   -   -          *   (ARG0*   (ARG1*   -
nw/wsj/19/wsj_1934   0    2            side      JJ          *      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    3         effects     NNS          *)     -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    4          -LCB-   -LRB-           *      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    5              of      IN       (PP*      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    6    cyclosporine      NN      (NP*))     -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    7          -RCB-   -RRB-           *)     -    -   -   -          *        *)       *   -
nw/wsj/19/wsj_1934   0    8            have     VBP       (VP*      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0    9            made     VBN       (VP*    make  02   -   -          *      (V*)       *   -
nw/wsj/19/wsj_1934   0   10             the      DT  (S(NP(NP*      -    -   -   -          *   (ARG1*        *   -
nw/wsj/19/wsj_1934   0   11         penalty      NN          *)     -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   12             for      IN       (PP*      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   13             its    PRP$       (NP*      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   14         success      NN        *)))     -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   15          rather      RB     (ADJP*      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   16            high      JJ      *)))))     -    -   -   -          *        *)       *)  -
nw/wsj/19/wsj_1934   0   17               ,       ,          *      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   18              ''      ''          *      -    -   -   -          *        *        *   -
nw/wsj/19/wsj_1934   0   19             Dr.     NNP       (NP*      -    -   -   -          *        *   (ARG0*   -
nw/wsj/19/wsj_1934   0   20          Starzl     NNP          *)     -    -   -   -    (PERSON)       *        *)  -
nw/wsj/19/wsj_1934   0   21            said     VBD       (VP*)    say  01   -   -          *        *      (V*)  -
nw/wsj/19/wsj_1934   0   22               .       .         *))     -    -   -   -          *        *        *   -

nw/wsj/19/wsj_1934   0    0          Dr.    NNP    (TOP(S(NP*      -    -   -   -          *   (ARG0*             *             *   -
nw/wsj/19/wsj_1934   0    1         Fung    NNP             *)     -    -   -   -    (PERSON)       *)            *             *   -
nw/wsj/19/wsj_1934   0    2         said    VBD          (VP*     say  01   -   -          *      (V*)            *             *   -
nw/wsj/19/wsj_1934   0    3         that     IN   (SBAR(SBAR*      -    -   -   -          *   (ARG1*             *             *   -
nw/wsj/19/wsj_1934   0    4           FK    NNP        (S(NP*      -    -   -   -          *        *        (ARG1*             *   -
nw/wsj/19/wsj_1934   0    5           -    HYPH             *      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0    6         506      CD             *)     -    -   -   -          *        *             *)            *   -
nw/wsj/19/wsj_1934   0    7        would     MD          (VP*      -    -   -   -          *        *    (ARGM-MOD*)            *   -
nw/wsj/19/wsj_1934   0    8          not     RB             *      -    -   -   -          *        *    (ARGM-NEG*)            *   -
nw/wsj/19/wsj_1934   0    9           be     VB          (VP*      be  01   -   -          *        *           (V*)            *   -
nw/wsj/19/wsj_1934   0   10    available     JJ        (ADJP*)     -    -   -   -          *        *        (ARG2*)            *   -
nw/wsj/19/wsj_1934   0   11           in     IN          (PP*      -    -   -   -          *        *    (ARGM-LOC*             *   -
nw/wsj/19/wsj_1934   0   12          the     DT          (NP*      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   13       market     NN            *))     -    -   -   -          *        *             *)            *   -
nw/wsj/19/wsj_1934   0   14          for     IN          (PP*      -    -   -   -          *        *    (ARGM-TMP*             *   -
nw/wsj/19/wsj_1934   0   15           at     RB  (NP(QP(ADVP*      -    -   -   -     (DATE*        *             *             *   -
nw/wsj/19/wsj_1934   0   16        least    RBS             *)     -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   17            a     DT             *)     -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   18         year     NN        *))))))     -    -   -   -          *)       *             *)            *   -
nw/wsj/19/wsj_1934   0   19            ,      ,             *      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   20          and     CC             *      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   21         that     IN        (SBAR*      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   22          the     DT        (S(NP*      -    -   -   -          *        *             *        (ARG0*   -
nw/wsj/19/wsj_1934   0   23          FDA    NNP             *      -    -   -   -       (ORG)       *             *             *   -
nw/wsj/19/wsj_1934   0   24     approval     NN             *      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   25      process     NN             *)     -    -   -   -          *        *             *             *)  -
nw/wsj/19/wsj_1934   0   26      usually     RB        (ADVP*)     -    -   -   -          *        *             *    (ARGM-TMP*)  -
nw/wsj/19/wsj_1934   0   27        takes    VBZ          (VP*    take  02   -   -          *        *             *           (V*)  -
nw/wsj/19/wsj_1934   0   28        three     CD       (NP(NP*      -    -   -   -     (DATE*        *             *        (ARG1*   -
nw/wsj/19/wsj_1934   0   29        years    NNS             *)     -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   30           to     TO             *      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   31         five     CD          (NP*      -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   32        years    NNS       *)))))))     -    -   -   -          *)       *)            *             *)  -
nw/wsj/19/wsj_1934   0   33            .      .            *))     -    -   -   -          *        *             *             *   -

nw/wsj/19/wsj_1934   0    0           There    EX      (TOP(S(NP*)        -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0    1             are   VBP            (VP*         be  02   -   -       *      (V*)       *          *   -
nw/wsj/19/wsj_1934   0    2              no    DT            (NP*         -    -   -   -       *   (ARG1*        *          *   -
nw/wsj/19/wsj_1934   0    3            firm    JJ               *         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0    4           plans   NNS               *         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0    5              to    TO          (S(VP*         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0    6          expand    VB            (VP*     expand  01   -   -       *        *      (V*)         *   -
nw/wsj/19/wsj_1934   0    7             the    DT            (NP*         -    -   -   -       *        *   (ARG1*          *   -
nw/wsj/19/wsj_1934   0    8    experimental    JJ               *         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0    9         program    NN               *)        -    -   -   -       *        *        *)         *   -
nw/wsj/19/wsj_1934   0   10          beyond    IN            (PP*         -    -   -   -       *        *   (ARG2*          *   -
nw/wsj/19/wsj_1934   0   11             the    DT      (NP(NP(NP*         -    -   -   -   (ORG*        *        *     (ARG0*   -
nw/wsj/19/wsj_1934   0   12      University   NNP               *)        -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   13              of    IN            (PP*         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   14      Pittsburgh   NNP          (NP*)))        -    -   -   -       *)       *        *          *)  -
nw/wsj/19/wsj_1934   0   15               ,     ,               *         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   16           whose   WP$     (SBAR(WHNP*         -    -   -   -       *        *        *   (R-ARG0*   -
nw/wsj/19/wsj_1934   0   17        hospital    NN               *)        -    -   -   -       *        *        *          *)  -
nw/wsj/19/wsj_1934   0   18        performs   VBZ          (S(VP*    perform  01   -   -       *        *        *        (V*)  -
nw/wsj/19/wsj_1934   0   19             the    DT         (NP(NP*         -    -   -   -       *        *        *     (ARG1*   -
nw/wsj/19/wsj_1934   0   20            most   JJS               *         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   21     transplants   NNS               *)        -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   22              in    IN            (PP*         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   23             the    DT            (NP*         -    -   -   -       *        *        *          *   -
nw/wsj/19/wsj_1934   0   24           world    NN   *)))))))))))))        -    -   -   -       *        *)       *)         *)  -
nw/wsj/19/wsj_1934   0   25               .     .              *))        -    -   -   -       *        *        *          *   -

nw/wsj/19/wsj_1934   0    0     Researchers    NNS    (TOP(S(S(NP*)         -    -   -   -           *        (ARG0*)            *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    1           could     MD            (VP*          -    -   -   -           *    (ARGM-MOD*)            *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    2             n't     RB               *          -    -   -   -           *    (ARGM-NEG*)            *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    3        estimate     VB            (VP*    estimate  01   1   -           *           (V*)            *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    4             the     DT      (NP(NP(NP*          -    -   -   -           *        (ARG1*             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    5            cost     NN               *)         -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    6              of     IN            (PP*          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    7             the     DT            (NP*          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    8            drug     NN             *)))         -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0    9            when    WRB   (SBAR(WHADVP*)         -    -   -   -           *             *    (ARGM-TMP*)        *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   10              it    PRP          (S(NP*)         -    -   -   -           *             *        (ARG0*)        *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   11         reaches    VBZ            (VP*       reach  01   -   -           *             *           (V*)        *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   12             the     DT            (NP*          -    -   -   -           *             *        (ARG1*         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   13          market     NN        *))))))))         -    -   -   -           *             *)            *)        *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   14               ,      ,               *          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   15             but     CC               *          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   16            they    PRP          (S(NP*)         -    -   -   -           *             *             *    (ARG0*)            *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   17            said    VBD            (VP*         say  01   -   -           *             *             *       (V*)            *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   18              FK    NNP     (SBAR(S(NP*          -    -   -   -           *             *             *    (ARG1*        (ARG0*         *        (ARG0*            *        *   -
nw/wsj/19/wsj_1934   0   19              -    HYPH               *          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   20            506      CD               *)         -    -   -   -           *             *             *         *             *)        *             *)           *        *   -
nw/wsj/19/wsj_1934   0   21            will     MD            (VP*          -    -   -   -           *             *             *         *    (ARGM-MOD*)        *    (ARGM-MOD*)           *        *   -
nw/wsj/19/wsj_1934   0   22          enable     VB         (VP(VP*      enable  01   1   -           *             *             *         *           (V*)        *             *            *        *   -
nw/wsj/19/wsj_1934   0   23        patients    NNS            (NP*)         -    -   -   -           *             *             *         *        (ARG2*)   (ARG0*)            *            *        *   -
nw/wsj/19/wsj_1934   0   24              to     TO          (S(VP*          -    -   -   -           *             *             *         *        (ARG1*         *             *            *        *   -
nw/wsj/19/wsj_1934   0   25             cut     VB            (VP*         cut  02   -   -           *             *             *         *             *       (V*)            *            *        *   -
nw/wsj/19/wsj_1934   0   26        hospital     NN            (NP*          -    -   -   -           *             *             *         *             *    (ARG1*             *            *        *   -
nw/wsj/19/wsj_1934   0   27           stays    NNS               *)         -    -   -   -           *             *             *         *             *         *)            *            *        *   -
nw/wsj/19/wsj_1934   0   28              by     IN            (PP*          -    -   -   -           *             *             *         *             *    (ARG2*             *            *        *   -
nw/wsj/19/wsj_1934   0   29             50      CD            (NP*          -    -   -   -   (PERCENT*             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   30               %     NN          *))))))         -    -   -   -           *)            *             *         *             *)        *)            *            *        *   -
nw/wsj/19/wsj_1934   0   31             and     CC               *          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   32          reduce     VB            (VP*      reduce  01   -   -           *             *             *         *             *         *           (V*)           *        *   -
nw/wsj/19/wsj_1934   0   33             the     DT         (NP(NP*          -    -   -   -           *             *             *         *             *         *        (ARG1*            *        *   -
nw/wsj/19/wsj_1934   0   34          number     NN               *)         -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   35              of     IN            (PP*          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   36           blood     NN         (NP(NP*          -    -   -   -           *             *             *         *             *         *             *       (ARG1*        *   -
nw/wsj/19/wsj_1934   0   37           tests    NNS               *)         -    -   -   -           *             *             *         *             *         *             *            *)       *   -
nw/wsj/19/wsj_1934   0   38            used    VBN            (VP*         use  01   -   -           *             *             *         *             *         *             *          (V*)       *   -
nw/wsj/19/wsj_1934   0   39              to     TO          (S(VP*          -    -   -   -           *             *             *         *             *         *             *       (ARG2*        *   -
nw/wsj/19/wsj_1934   0   40         monitor     VB            (VP*     monitor  01   1   -           *             *             *         *             *         *             *            *      (V*)  -
nw/wsj/19/wsj_1934   0   41             the     DT         (NP(NP*          -    -   -   -           *             *             *         *             *         *             *            *   (ARG1*   -
nw/wsj/19/wsj_1934   0   42          dosage     NN               *)         -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   43              of     IN            (PP*          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   44    cyclosporine     JJ         (NP(NP*)         -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   45             and     CC               *          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   46           other     JJ            (NP*          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   47           drugs    NNS         *)))))))         -    -   -   -           *             *             *         *             *         *             *            *)       *)  -
nw/wsj/19/wsj_1934   0   48           among     IN            (PP*          -    -   -   -           *             *             *         *             *         *             *   (ARGM-LOC*        *   -
nw/wsj/19/wsj_1934   0   49      transplant     NN            (NP*          -    -   -   -           *             *             *         *             *         *             *            *        *   -
nw/wsj/19/wsj_1934   0   50      recipients    NNS   *)))))))))))))         -    -   -   -           *             *             *         *)            *         *             *)           *)       *   -
nw/wsj/19/wsj_1934   0   51               .      .              *))         -    -   -   -           *             *             *         *             *         *             *            *        *   -

nw/wsj/19/wsj_1934   0    0           Dr.   NNP        (TOP(S(NP*          -    -   -   -          *   (ARG0*             *             *   -
nw/wsj/19/wsj_1934   0    1        Starzl   NNP                 *)         -    -   -   -    (PERSON)       *)            *             *   -
nw/wsj/19/wsj_1934   0    2          said   VBD              (VP*         say  01   -   -          *      (V*)            *             *   -
nw/wsj/19/wsj_1934   0    3           the    DT  (SBAR(SBAR(S(NP*          -    -   -   -          *   (ARG1*        (ARG1*             *   -
nw/wsj/19/wsj_1934   0    4      research    NN                 *)   research   -   1   -          *        *             *)            *   -
nw/wsj/19/wsj_1934   0    5           has   VBZ              (VP*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0    6          been   VBN              (VP*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0    7       largely    RB            (ADVP*)         -    -   -   -          *        *    (ARGM-ADV*)            *   -
nw/wsj/19/wsj_1934   0    8      financed   VBN              (VP*     finance  01   1   -          *        *           (V*)            *   -
nw/wsj/19/wsj_1934   0    9            by    IN           (PP(PP*          -    -   -   -          *        *        (ARG0*             *   -
nw/wsj/19/wsj_1934   0   10           the    DT           (NP(NP*          -    -   -   -      (ORG*        *             *             *   -
nw/wsj/19/wsj_1934   0   11      National   NNP                 *          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   12     Institute   NNP                 *)         -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   13            of    IN              (PP*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   14        Health   NNP           (NP*))))         -    -   -   -          *)       *             *)            *   -
nw/wsj/19/wsj_1934   0   15           and    CC                 *          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   16            by    IN              (PP*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   17    university    NN              (NP*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   18         funds   NNS          *))))))))         -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   19             ,     ,                 *          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   20           and    CC                 *          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   21          that    IN            (SBAR*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   22      Fujisawa   NNP            (S(NP*)         -    -   -   -       (ORG)       *             *        (ARG0*)  -
nw/wsj/19/wsj_1934   0   23           did   VBD              (VP*          -    -   -   -          *        *             *             *   -
nw/wsj/19/wsj_1934   0   24           n't    RB                 *          -    -   -   -          *        *             *    (ARGM-NEG*)  -
nw/wsj/19/wsj_1934   0   25          give    VB              (VP*        give  01   -   -          *        *             *           (V*)  -
nw/wsj/19/wsj_1934   0   26           the    DT              (NP*          -    -   -   -          *        *             *        (ARG2*   -
nw/wsj/19/wsj_1934   0   27      hospital    NN                 *)         -    -   -   -          *        *             *             *)  -
nw/wsj/19/wsj_1934   0   28           any    DT              (NP*          -    -   -   -          *        *             *        (ARG1*   -
nw/wsj/19/wsj_1934   0   29        grants   NNS           *)))))))         -    -   -   -          *        *)            *             *)  -
nw/wsj/19/wsj_1934   0   30             .     .                *))         -    -   -   -          *        *             *             *   -

nw/wsj/19/wsj_1934   0    0           He   PRP   (TOP(S(NP*)     -    -   -   -   *    (ARG0*)       *   -
nw/wsj/19/wsj_1934   0    1         said   VBD         (VP*     say  01   -   -   *       (V*)       *   -
nw/wsj/19/wsj_1934   0    2         that    IN       (SBAR*      -    -   -   -   *    (ARG1*        *   -
nw/wsj/19/wsj_1934   0    3          the    DT       (S(NP*      -    -   -   -   *         *   (ARG0*   -
nw/wsj/19/wsj_1934   0    4     research    NN            *      -    -   -   -   *         *        *   -
nw/wsj/19/wsj_1934   0    5         team    NN            *)     -    -   -   -   *         *        *)  -
nw/wsj/19/wsj_1934   0    6          had   VBD         (VP*    have  03   -   -   *         *      (V*)  -
nw/wsj/19/wsj_1934   0    7           no    DT      (NP(NP*      -    -   -   -   *         *   (ARG1*   -
nw/wsj/19/wsj_1934   0    8    financial    JJ            *      -    -   -   -   *         *        *   -
nw/wsj/19/wsj_1934   0    9        stake    NN            *)     -    -   -   -   *         *        *   -
nw/wsj/19/wsj_1934   0   10           in    IN         (PP*      -    -   -   -   *         *        *   -
nw/wsj/19/wsj_1934   0   11          the    DT         (NP*      -    -   -   -   *         *        *   -
nw/wsj/19/wsj_1934   0   12         drug    NN      *)))))))     -    -   -   -   *         *)       *)  -
nw/wsj/19/wsj_1934   0   13            .     .           *))     -    -   -   -   *         *        *   -

nw/wsj/19/wsj_1934   0    0           ``     ``         (TOP(S*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    1           We    PRP        (S(S(NP*)       -    -   -   -          *       (ARG0*)       *             *       (ARG1*        *        *             *   -
nw/wsj/19/wsj_1934   0    2          've    VBP            (VP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    3        known    VBN            (VP*      know  01   1   -          *          (V*)       *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    4          for     IN            (PP*        -    -   -   -          *   (ARGM-TMP*        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    5          six     CD            (NP*        -    -   -   -     (DATE*            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    6       months    NNS              *))       -    -   -   -          *)           *)       *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    7          the     DT         (NP(NP*        -    -   -   -          *       (ARG1*        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    8       effect     NN               *)       -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0    9           of     IN            (PP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   10         this     DT            (NP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   11         drug     NN          *))))))       -    -   -   -          *            *)       *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   12            ,      ,               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   13          and     CC               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   14          our   PRP$       (S(NP(NP*        -    -   -   -          *            *   (ARG1*             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   15       advice     NN               *)       -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   16           to     IN            (PP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   17          our   PRP$            (NP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   18       people    NNS             *)))       -    -   -   -          *            *        *)            *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   19          has    VBZ            (VP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   20         been    VBN            (VP*        be  01   -   -          *            *      (V*)            *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   21          not     RB             (S*        -    -   -   -          *            *   (ARG2*    (ARGM-NEG*)           *        *        *             *   -
nw/wsj/19/wsj_1934   0   22           to     TO            (VP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   23          buy     VB            (VP*       buy  01   -   -          *            *        *           (V*)           *        *        *             *   -
nw/wsj/19/wsj_1934   0   24          the     DT         (NP(NP*        -    -   -   -          *            *        *        (ARG1*            *        *        *             *   -
nw/wsj/19/wsj_1934   0   25      company     NN               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   26           's    POS               *)       -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   27        stock     NN        *))))))))       -    -   -   -          *            *        *)            *)           *)       *        *             *   -
nw/wsj/19/wsj_1934   0   28            ,      ,               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   29           ''     ''               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   30          Dr.    NNP            (NP*        -    -   -   -          *            *        *             *       (ARG0*   (ARG0*        *             *   -
nw/wsj/19/wsj_1934   0   31       Starzl    NNP               *)       -    -   -   -    (PERSON)           *        *             *            *)       *)       *             *   -
nw/wsj/19/wsj_1934   0   32         said    VBD            (VP*       say  01   -   -          *            *        *             *          (V*)       *        *             *   -
nw/wsj/19/wsj_1934   0   33            ,      ,               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   34       adding    VBG          (S(VP*       add  01   -   -          *            *        *             *   (ARGM-PRD*      (V*)       *             *   -
nw/wsj/19/wsj_1934   0   35         that     IN          (SBAR*        -    -   -   -          *            *        *             *            *   (ARG1*        *             *   -
nw/wsj/19/wsj_1934   0   36    profiting    VBG        (S(S(VP*    profit  01   1   -          *            *        *             *            *        *      (V*)       (ARG1*   -
nw/wsj/19/wsj_1934   0   37         from     IN            (PP*        -    -   -   -          *            *        *             *            *        *   (ARG1*             *   -
nw/wsj/19/wsj_1934   0   38           FK    NNP            (NP*        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   39           -    HYPH               *        -    -   -   -          *            *        *             *            *        *        *             *   -
nw/wsj/19/wsj_1934   0   40         506      CD            *))))       -    -   -   -          *            *        *             *            *        *        *)            *)  -
nw/wsj/19/wsj_1934   0   41        would     MD            (VP*        -    -   -   -          *            *        *             *            *        *        *    (ARGM-MOD*)  -
nw/wsj/19/wsj_1934   0   42          n't     RB               *        -    -   -   -          *            *        *             *            *        *        *    (ARGM-NEG*)  -
nw/wsj/19/wsj_1934   0   43           be     VB            (VP*        be  01   -   -          *            *        *             *            *        *        *           (V*)  -
nw/wsj/19/wsj_1934   0   44      ethical     JJ   (ADJP*))))))))       -    -   -   -          *            *        *             *            *)       *)       *        (ARG2*)  -
nw/wsj/19/wsj_1934   0   45            .      .              *))       -    -   -   -          *            *        *             *            *        *        *             *   -

#end document
